Literature DB >> 25796131

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study.

Elise Cuyvers1, Julie van der Zee1, Karolien Bettens1, Sebastiaan Engelborghs2, Mathieu Vandenbulcke3, Caroline Robberecht1, Lubina Dillen1, Céline Merlin1, Nathalie Geerts1, Caroline Graff4, Håkan Thonberg4, Huei-Hsin Chiang5, Pau Pastor6, Sara Ortega-Cubero7, Maria A Pastor8, Janine Diehl-Schmid9, Panagiotis Alexopoulos9, Luisa Benussi10, Roberta Ghidoni10, Giuliano Binetti10, Benedetta Nacmias11, Sandro Sorbi11, Raquel Sanchez-Valle12, Albert Lladó12, Ellen Gelpi13, Maria Rosário Almeida14, Isabel Santana14, Jordi Clarimon15, Alberto Lleó15, Juan Fortea15, Alexandre de Mendonça16, Madalena Martins16, Barbara Borroni17, Alessandro Padovani17, Radoslav Matěj18, Zdenek Rohan19, Agustín Ruiz20, Giovanni B Frisoni21, Gian Maria Fabrizi22, Rik Vandenberghe23, Peter P De Deyn24, Christine Van Broeckhoven25, Kristel Sleegers26.   

Abstract

Meta-analysis of existing genome-wide association studies on Alzheimer's disease (AD) showed subgenome-wide association of an intronic variant in the sequestosome 1 (SQSTM1) gene with AD. We performed targeted resequencing of SQSTM1 in Flanders-Belgian AD patients selected to be enriched for a genetic background (n = 435) and geographically matched nonaffected individuals (n = 872) to investigate the role of both common and rare SQSTM1 variants. Results were extended to the European early-onset dementia cohorts (926 early-onset Alzheimer's disease [EOAD] patients and 1476 nonaffected individuals). Of the 61 detected exonic variants in SQSTM1, the majority were rare (n = 57). Rare variant (minor allele frequency <0.01) burden analysis did not reveal an increased frequency of rare variants in EOAD patients in any of the separate study populations nor when meta-analyzing all cohorts. Common variants p.D292= and p.R312= showed nominal association with AD (odds ratiop.D292= = 1.11 [95% confidence interval = 1-1.22], p = 0.04), only when including the Flanders-Belgian cohort in the meta-analysis. We cannot exclude a role of SQSTM1 genetic variability in late-onset AD, but our data indicate that SQSTM1 does not play a major role in the etiology of EOAD.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; European early-onset dementia consortium; Meta-analysis; Rare variants; SQSTM1/p62

Mesh:

Substances:

Year:  2015        PMID: 25796131     DOI: 10.1016/j.neurobiolaging.2015.02.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Selective autophagy as a potential therapeutic target for neurodegenerative disorders.

Authors:  Aurora Scrivo; Mathieu Bourdenx; Olatz Pampliega; Ana Maria Cuervo
Journal:  Lancet Neurol       Date:  2018-09       Impact factor: 44.182

Review 2.  Macroautophagy in CNS health and disease.

Authors:  Christopher J Griffey; Ai Yamamoto
Journal:  Nat Rev Neurosci       Date:  2022-05-03       Impact factor: 38.755

3.  TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations.

Authors:  YouJin Lee; Per Harald Jonson; Jaakko Sarparanta; Johanna Palmio; Mohona Sarkar; Anna Vihola; Anni Evilä; Tiina Suominen; Sini Penttilä; Marco Savarese; Mridul Johari; Marie-Christine Minot; David Hilton-Jones; Paul Maddison; Patrick Chinnery; Jens Reimann; Cornelia Kornblum; Torsten Kraya; Stephan Zierz; Carolyn Sue; Hans Goebel; Asim Azfer; Stuart H Ralston; Peter Hackman; Robert C Bucelli; J Paul Taylor; Conrad C Weihl; Bjarne Udd
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

4.  Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro M Machado; Stefen Brady; Janice L Holton; Alan M Pittman; Deborah Hughes; Estelle Healy; Matthew Parton; David Hilton-Jones; Perry B Shieh; Merrilee Needham; Christina Liang; Edmar Zanoteli; Leonardo Valente de Camargo; Boel De Paepe; Jan De Bleecker; Aziz Shaibani; Michela Ripolone; Raffaella Violano; Maurizio Moggio; Richard J Barohn; Mazen M Dimachkie; Marina Mora; Renato Mantegazza; Simona Zanotti; Andrew B Singleton; Michael G Hanna; Henry Houlden
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

5.  Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues.

Authors:  Michelle B Chen; Andrew C Yang; Hanadie Yousef; Davis Lee; Winnie Chen; Nicholas Schaum; Benoit Lehallier; Stephen R Quake; Tony Wyss-Coray
Journal:  Cell Rep       Date:  2020-03-31       Impact factor: 9.423

Review 6.  Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics.

Authors:  Joseph A White; Rupkatha Banerjee; Shermali Gunawardena
Journal:  Mar Drugs       Date:  2016-05-19       Impact factor: 5.118

7.  A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease.

Authors:  Jan Verheijen; Tobi Van den Bossche; Julie van der Zee; Sebastiaan Engelborghs; Raquel Sanchez-Valle; Albert Lladó; Caroline Graff; Håkan Thonberg; Pau Pastor; Sara Ortega-Cubero; Maria A Pastor; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Jordi Clarimon; Alberto Lleó; Juan Fortea; Alexandre de Mendonça; Madalena Martins; Oriol Grau-Rivera; Ellen Gelpi; Karolien Bettens; Ligia Mateiu; Lubina Dillen; Patrick Cras; Peter P De Deyn; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Acta Neuropathol       Date:  2016-03-30       Impact factor: 17.088

8.  Exome sequencing in dementia with Lewy bodies.

Authors:  M J Keogh; M Kurzawa-Akanbi; H Griffin; K Douroudis; K L Ayers; R I Hussein; G Hudson; A Pyle; H J Cordell; J Attems; I G McKeith; J T O'Brien; D J Burn; C M Morris; A J Thomas; P F Chinnery
Journal:  Transl Psychiatry       Date:  2016-02-02       Impact factor: 6.222

9.  Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.

Authors:  Srinivas Ayyadevara; Meenakshisundaram Balasubramaniam; Paul A Parcon; Steven W Barger; W Sue T Griffin; Ramani Alla; Alan J Tackett; Samuel G Mackintosh; Emanuel Petricoin; Weidong Zhou; Robert J Shmookler Reis
Journal:  Aging Cell       Date:  2016-07-23       Impact factor: 9.304

10.  Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.

Authors:  Rita Cacace; Tobi Van den Bossche; Sebastiaan Engelborghs; Nathalie Geerts; Annelies Laureys; Lubina Dillen; Caroline Graff; Håkan Thonberg; Huei-Hsin Chiang; Pau Pastor; Sara Ortega-Cubero; Maria A Pastor; Janine Diehl-Schmid; Panagiotis Alexopoulos; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Benedetta Nacmias; Sandro Sorbi; Raquel Sanchez-Valle; Albert Lladó; Ellen Gelpi; Maria Rosário Almeida; Isabel Santana; Magda Tsolaki; Maria Koutroumani; Jordi Clarimon; Alberto Lleó; Juan Fortea; Alexandre de Mendonça; Madalena Martins; Barbara Borroni; Alessandro Padovani; Radoslav Matej; Zdenek Rohan; Mathieu Vandenbulcke; Rik Vandenberghe; Peter P De Deyn; Patrick Cras; Julie van der Zee; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2015-10-14       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.